Bone Biologics Corp (NASDAQ: BBLG)
$1.18
+0.0300 ( +2.61% ) 23.9K
Bone Biologics Corp is a healthcare solutions provider based in the United States. As a biotechnology firm, it engages its efforts in developing therapeutics to aid bone regeneration. The company's portfolio comprises its lead product, NELL-1, which is a bone void filler. Bone Biologics' technology has applications in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine.
Market Data
Open
$1.18
Previous close
$1.15
Volume
23.9K
Market cap
$1.25M
Day range
$1.14 - $1.23
52 week range
$1.00 - $12.32
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 16 | Jun 20, 2024 |
10-q | Quarterly Reports | 58 | May 14, 2024 |
8-k | 8K-related | 15 | Mar 15, 2024 |
8-k | 8K-related | 23 | Mar 06, 2024 |
8-k | 8K-related | 17 | Mar 01, 2024 |
10-k | Annual reports | 67 | Feb 21, 2024 |
4 | Insider transactions | 1 | Jan 19, 2024 |
4 | Insider transactions | 1 | Jan 19, 2024 |
8-k | 8K-related | 13 | Jan 12, 2024 |
8-k | 8K-related | 15 | Jan 11, 2024 |